KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia.

Matthias Wölfl, Muna Qayed, Maria Isabel Benitez Carabante, Tomas Sykora, Halvard Bonig, Anita Lawitschka, Cristina Diaz-de-Heredia

Front Pediatr 9 784377

PMID35071133
PMCIDPMC8771910
DOI10.3389/fped.2021.784377
发表日期2022-01-24
摘要

摘要

Acute graft-versus-host disease (aGvHD) continues to be a leading cause of morbidity and mortality following allogeneic haematopoietic stem cell transplantation (HSCT). However, higher event-free survival (EFS) was observed in patients with acute lymphoblastic leukaemia (ALL) and grade II aGvHD vs. patients with no or grade I GvHD in the randomised, controlled, open-label, international, multicentre Phase III For Omitting Radiation Under Majority age (FORUM) trial. This finding suggests that moderate-severity aGvHD is associated with a graft-versus-leukaemia effect which protects against leukaemia recurrence. In order to optimise the benefits of HSCT for leukaemia patients, reduction of non-relapse mortality-which is predominantly caused by severe GvHD-is of utmost importance. Herein, we review contemporary prophylaxis and treatment options for aGvHD in children with ALL and the key challenges of aGvHD management, focusing on maintaining the graft-versus-leukaemia effect without increasing the severity of GvHD.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。